PapersFlow Research Brief
Cytokine Signaling Pathways and Interactions
Research Guide
What is Cytokine Signaling Pathways and Interactions?
Cytokine signaling pathways and interactions refer to the molecular cascades, primarily involving the JAK/STAT pathway with key roles for STAT3, IL-6, and SOCS proteins, that mediate communication between cytokines and cells to regulate inflammation, immune responses, and tumor microenvironments in cancer.
This field encompasses 60,906 papers examining STAT3's functions in cancer inflammation and immunity through cytokine signaling and JAK/STAT regulation. Research highlights the interplay of STAT3, IL-6, and SOCS proteins in transcriptional control and tumor progression. Studies also address modulation of immune responses within the tumor microenvironment.
Topic Hierarchy
Research Sub-Topics
STAT3 Activation in Tumor Microenvironment
Researchers investigate STAT3 signaling in tumor-associated macrophages, MDSCs, and CAFs promoting immunosuppression and angiogenesis. Spatial-temporal dynamics of p-STAT3 correlate with T-cell exclusion and therapy resistance.
IL-6 JAK STAT3 Signaling
This sub-topic covers IL-6 trans-signaling via sIL-6R/gp130, JAK1/2 activation, and STAT3 Y705 phosphorylation driving acute phase responses. Dysregulated gp130 mutations underlie inflammatory diseases and malignancies.
SOCS3 Negative Regulation of STAT3
Studies elucidate SOCS3 induction via STAT3 feedback, E3 ligase-mediated JAK degradation, and PIAS3 sumoylation inhibiting STAT3 DNA binding. SOCS3 loss amplifies cytokine hypersensitivity in autoimmunity and cancer.
STAT3 Transcriptional Targets in Cancer
Research employs ChIP-seq and CRISPR screens to map STAT3 cistrome regulating c-Myc, Bcl-xL, VEGF, and MMPs. Enhancer hijacking and super-enhancer dependencies drive oncogene addiction in STAT3-dependent tumors.
STAT3 Inhibitors Cancer Therapy
Investigators develop direct inhibitors (OPB-51602, napabucasin), indirect (ruxolitinib), and degraders targeting STAT3 SH2 domain or DBD. Clinical trials assess combinations with PD-1 blockade for immunogenic tumors.
Why It Matters
Cytokine signaling pathways drive chronic inflammation in diseases like cancer, asthma, rheumatoid arthritis, and inflammatory bowel disease, where cytokines recruit immune cells to amplify inflammation, as shown by Barnes and Karin (1997) in 'Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases,' linking NF-κB activation to these conditions. In oncology, IL-6 signaling via STAT3 promotes tumor progression and immune evasion in the tumor microenvironment, detailed by Tanaka et al. (2014) in 'IL-6 in Inflammation, Immunity, and Disease,' which notes IL-6's role in acute phase responses and hematopoiesis during infections. Coussens and Werb (2002) in 'Inflammation and cancer' (14,911 citations) demonstrate how inflammatory cells and cytokines foster tumorigenesis, providing targets for therapies inhibiting JAK/STAT or NF-κB pathways to disrupt cancer-promoting inflammation.
Reading Guide
Where to Start
'Inflammation and cancer' by Coussens and Werb (2002), as it provides a foundational overview of cytokine-driven inflammation in tumorigenesis with 14,911 citations, establishing core concepts before diving into pathways.
Key Papers Explained
Coussens and Werb (2002) 'Inflammation and cancer' sets the stage for cytokine roles in tumors, which Darnell et al. (1994) 'Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins' mechanistically details via JAK/STAT signaling (6,055 citations). Tanaka et al. (2014) 'IL-6 in Inflammation, Immunity, and Disease' builds on this by focusing on IL-6-STAT3 interactions (4,677 citations), while Lawrence (2009) 'The Nuclear Factor NF-κB Pathway in Inflammation' connects NF-κB crosstalk (4,662 citations). Lemmon and Schlessinger (2010) 'Cell Signaling by Receptor Tyrosine Kinases' (7,761 citations) extends to upstream receptor inputs.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research in this 60,906-paper field centers on STAT3 regulation by IL-6 and SOCS in transcriptional control of cancer immunity, with emphasis on tumor microenvironment modulation. No recent preprints or news from the last 12 months indicate steady focus on established pathways like JAK/STAT and NF-κB without new disruptions.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Inflammation and cancer | 2002 | Nature | 14.9K | ✓ |
| 2 | Cell Signaling by Receptor Tyrosine Kinases | 2010 | Cell | 7.8K | ✓ |
| 3 | Osteoclast differentiation and activation | 2003 | Nature | 6.5K | ✕ |
| 4 | Jak-STAT Pathways and Transcriptional Activation in Response t... | 1994 | Science | 6.1K | ✕ |
| 5 | Recognition of double-stranded RNA and activation of NF-κB by ... | 2001 | Nature | 6.0K | ✕ |
| 6 | THE NF-κB AND IκB PROTEINS: New Discoveries and Insights | 1996 | Annual Review of Immun... | 5.9K | ✕ |
| 7 | Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast... | 1998 | Cell | 5.4K | ✓ |
| 8 | IL-6 in Inflammation, Immunity, and Disease | 2014 | Cold Spring Harbor Per... | 4.7K | ✓ |
| 9 | Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic ... | 1997 | New England Journal of... | 4.7K | ✕ |
| 10 | The Nuclear Factor NF- B Pathway in Inflammation | 2009 | Cold Spring Harbor Per... | 4.7K | ✓ |
Frequently Asked Questions
What is the role of IL-6 in cytokine signaling?
IL-6 is produced promptly in response to infections and tissue injuries, stimulating acute phase responses, hematopoiesis, and immune reactions. Its expression is controlled by transcriptional and posttranscriptional mechanisms. Tanaka et al. (2014) in 'IL-6 in Inflammation, Immunity, and Disease' describe IL-6's contributions to host defense and its dysregulation in disease.
How does the JAK/STAT pathway function in cytokine signaling?
IFN-receptor interaction activates Jak family kinases, leading to direct signal transduction to the nucleus for transcriptional activation. This pathway responds to IFNs and other extracellular signaling proteins. Darnell et al. (1994) in 'Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins' uncovered this mechanism through interferon studies.
What is STAT3's involvement in cancer inflammation?
STAT3 mediates cytokine signaling in the JAK/STAT pathway, regulating inflammation and immunity in the tumor microenvironment. It interacts with IL-6 and SOCS proteins for transcriptional control. This cluster of 60,906 papers emphasizes STAT3's impact on cancer progression.
How does NF-κB contribute to cytokine signaling in inflammation?
NF-κB controls proinflammatory genes including cytokines, chemokines, and adhesion molecules, acting as a central regulator in immunological processes. Genetic evidence confirms its proinflammatory role. Lawrence (2009) in 'The Nuclear Factor NF-κB Pathway in Inflammation' details this pathway's function.
What are key interactions in the tumor microenvironment?
Cytokine signaling via STAT3, IL-6, and JAK/STAT modulates immune responses and promotes tumor progression. Inflammation fosters tumorigenesis through cytokine-mediated cell recruitment. Coussens and Werb (2002) in 'Inflammation and cancer' link these interactions to cancer development.
Open Research Questions
- ? How do SOCS proteins precisely regulate STAT3 activity in specific cytokine contexts within tumors?
- ? What are the differential roles of STAT3 isoforms in modulating tumor microenvironment immunity?
- ? How do JAK/STAT and NF-κB pathways crosstalk to sustain chronic inflammation in cancer?
- ? What mechanisms control IL-6 posttranscriptional regulation during tumor progression?
- ? How does STAT3 influence interactions between immune cells and cancer cells in the tumor niche?
Recent Trends
The field maintains 60,906 works with no specified 5-year growth rate, reflecting sustained interest in STAT3, IL-6, JAK/STAT, and SOCS in cancer inflammation.
High-citation classics like Coussens and Werb 'Inflammation and cancer' (14,911 citations) and Lemmon and Schlessinger (2010) 'Cell Signaling by Receptor Tyrosine Kinases' (7,761 citations) anchor research.
2002Absence of recent preprints or news in the last 12 months suggests consolidation around core pathways without major shifts.
Research Cytokine Signaling Pathways and Interactions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cytokine Signaling Pathways and Interactions with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers